Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of Its Next Generation AI Drug Repurposing Platform

CHICAGO, IL / ACCESSWIRE / March 21, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative R&D,

AccesswireMar 21 09:45 ET

Cosmos Health To Receive Regulatory Approval For C-Scrub Disinfectant In The UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU; No Financial Terms Of Purchase Order Disclosed

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nu

BenzingaMar 19 10:13 ET

Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market

Yahoo FinanceMar 19 10:10 ET

Express News | Cosmos Health Receives Regulatory Approval To Sell Sky Premium Life Products In UAE Nutritional Supplements Market; Secures Initial Purchase Orders

Moomoo 24/7Mar 18 09:28 ET

Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders

CHICAGO, IL / ACCESSWIRE / March 18, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative R&D,

AccesswireMar 18 09:25 ET

Cosmos Health Successfully Completes Acquisition of Pharmatrade's Assets; Expects to Increase FY 2024 Annual Revenue by Over $5 Million

CHICAGO, IL / ACCESSWIRE / February 29, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative

AccesswireFeb 29 09:25 ET